198 related articles for article (PubMed ID: 10372931)
1. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with Child's grade A or B cirrhosis: a multivariate analysis of prognostic factors.
Savastano S; Miotto D; Casarrubea G; Teso S; Chiesura-Corona M; Feltrin GP
J Clin Gastroenterol; 1999 Jun; 28(4):334-40. PubMed ID: 10372931
[TBL] [Abstract][Full Text] [Related]
2. Segmental transcatheter arterial chemoembolization treatment in patients with cirrhosis and inoperable hepatocellular carcinomas.
Saccheri S; Lovaria A; Sangiovanni A; Nicolini A; De Fazio C; Ronchi G; Fasani P; Del Ninno E; Colombo M
J Vasc Interv Radiol; 2002 Oct; 13(10):995-9. PubMed ID: 12397120
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of hepatocellular carcinoma associated with Child class B and C cirrhosis in relation to treatment: a multivariate analysis of 411 patients at a single center.
Ueno S; Tanabe G; Nuruki K; Oketani M; Komorizono Y; Hokotate H; Fukukura Y; Baba Y; Imamura Y; Aikou T
J Hepatobiliary Pancreat Surg; 2002; 9(4):469-77. PubMed ID: 12483269
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes of transcatheter arterial chemoembolization with autologous blood clot for unresectable hepatocellular carcinoma.
Gunji T; Kawauchi N; Akahane M; Watanabe K; Kanamori H; Ohnishi S
Int J Oncol; 2002 Aug; 21(2):427-32. PubMed ID: 12118341
[TBL] [Abstract][Full Text] [Related]
5. Long-term survival of Taiwanese patients with hepatocellular carcinoma after combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection.
Li YH; Wang CS; Liao LY; Wang CK; Shih LS; Chen RC; Chen PH
J Formos Med Assoc; 2003 Mar; 102(3):141-6. PubMed ID: 12783129
[TBL] [Abstract][Full Text] [Related]
6. Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case-controlled study.
Biselli M; Andreone P; Gramenzi A; Trevisani F; Cursaro C; Rossi C; Ricca Rosellini S; Cammà C; Lorenzini S; Stefanini GF; Gasbarrini G; Bernardi M
Clin Gastroenterol Hepatol; 2005 Sep; 3(9):918-25. PubMed ID: 16234031
[TBL] [Abstract][Full Text] [Related]
7. Chemoembolization outcomes for hepatocellular carcinoma in cirrhotic patients with compromised liver function.
Dorn DP; Bryant MK; Zarzour J; Smith JK; Redden DT; Saddekni S; Abdel Aal AK; Gray S; White J; Eckhoff DE; DuBay DA
HPB (Oxford); 2014 Jul; 16(7):648-55. PubMed ID: 25072067
[TBL] [Abstract][Full Text] [Related]
8. Liver failure after transarterial chemoembolization for patients with hepatocellular carcinoma and ascites: incidence, risk factors, and prognostic prediction.
Hsin IF; Hsu CY; Huang HC; Huang YH; Lin HC; Lee RC; Chiang JH; Lee FY; Huo TI; Lee SD
J Clin Gastroenterol; 2011 Jul; 45(6):556-62. PubMed ID: 21666547
[TBL] [Abstract][Full Text] [Related]
9. Treatment of hepatocellular carcinoma associated with advanced cirrhosis by transcatheter arterial chemoembolization using autologous blood clot: a preliminary report.
Gunji T; Kawauchi N; Ohnishi S; Ishikawa T; Nakagama H; Kaneko T; Moriyama T; Matsuhashi N; Yazaki Y; Imawari M
Hepatology; 1992 Feb; 15(2):252-7. PubMed ID: 1310476
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
Liu C; Sun L; Xu J; Zhao Y
World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
[TBL] [Abstract][Full Text] [Related]
11. A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis.
Schwartz ME; Sung M; Mor E; Fisher A; Popescu I; Fiel I; Sheiner P; Emre S; Guy S; Miller CM
J Am Coll Surg; 1995 May; 180(5):596-603. PubMed ID: 7749537
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy.
Pompili M; Rapaccini GL; Covino M; Pignataro G; Caturelli E; Siena DA; Villani MR; Cedrone A; Gasbarrini G
Cancer; 2001 Jul; 92(1):126-35. PubMed ID: 11443618
[TBL] [Abstract][Full Text] [Related]
13. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW
Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
[TBL] [Abstract][Full Text] [Related]
14. Transcatheter arterial chemoembolisation for hepatocellular carcinoma in cirrhosis: survival rate and prognostic factors.
Olivo M; Valenza F; Buccellato A; Scala L; Virdone R; Sciarrino E; Di Piazza S; Marrone C; Orlando A; Fusco G; Madonia S; Cottone M
Dig Liver Dis; 2010 Jul; 42(7):515-9. PubMed ID: 19914153
[TBL] [Abstract][Full Text] [Related]
15. High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma.
Chen MS; Li JQ; Zhang YQ; Lu LX; Zhang WZ; Yuan YF; Guo YP; Lin XJ; Li GH
World J Gastroenterol; 2002 Feb; 8(1):74-8. PubMed ID: 11833075
[TBL] [Abstract][Full Text] [Related]
16. The long term efficacy of combined transcatheter arterial embolization and percutaneous ethanol injection in the treatment of patients with large hepatocellular carcinoma and cirrhosis.
Tanaka K; Nakamura S; Numata K; Kondo M; Morita K; Kitamura T; Saito S; Kiba T; Okazaki H; Sekihara H
Cancer; 1998 Jan; 82(1):78-85. PubMed ID: 9428482
[TBL] [Abstract][Full Text] [Related]
17. [A comparison of patients with hepatocellular carcinoma between a short-term (less than 6 months) survival group and a long-term (over 24 months) survival group after treatment with transcatheter arterial chemoembolization].
Kang IK; Kim SW; Hahn SH; Cho SC; Gham CW; Lee DH
Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):189-200. PubMed ID: 12499805
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive treatments for hepatocellular carcinoma with tumor thrombus in major portal vein.
Ye HH; Ye JZ; Xie ZB; Peng YC; Chen J; Ma L; Bai T; Chen JZ; Lu Z; Qin HG; Xiang BD; Li LQ
World J Gastroenterol; 2016 Apr; 22(13):3632-43. PubMed ID: 27053855
[TBL] [Abstract][Full Text] [Related]
19. A comparison of chemoembolization with conventional chemotherapy and symptomatic treatment in cirrhotic patients with hepatocellular carcinoma.
Bayraktar Y; Balkanci F; Kayhan B; Uzunalimoglu B; Gokoz A; Ozisik Y; Gurakar A; Van Thiel DH; Firat D
Hepatogastroenterology; 1996; 43(9):681-7. PubMed ID: 8799415
[TBL] [Abstract][Full Text] [Related]
20. No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. Italian Cooperative HCC Study Group.
Livraghi T; Bolondi L; Buscarini L; Cottone M; Mazziotti A; Morabito A; Torzilli G
J Hepatol; 1995 May; 22(5):522-6. PubMed ID: 7650331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
